progression of maculopathy chloroquine retinal toxicity maculopathy chloroquine retinal toxicity
Conditions
Interventions
progression of maculopathy after drug cessation in eyes with chloroquine retinal toxicity
Prevention
chloroquine retinal toxicity
Sponsors
Faculty of Medicine Siriraj Hospital, Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over age 18 years with diagnosis of chloroquine retinopathy from 2000 to 2016
Exclusion criteria
Exclusion criteria: 1. Patients with coexisting or uncertain retinal or macular diseases from other causes 2. The poor quality of investigation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression of maculopathy after drug cessation in eyes with chloroquine retinal toxicity At first visit, 6month, 1year, 3year, 5year time point after drug cessation in eyes with chloroquine retinal toxicity Retrospective chart review from medical record | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of the progression of maculopathy after the drug cessations At first visit, 6month, 1year, 3year, 5year time point after drug cessation in eyes with chloroquine retinal toxicity Retrospective chart review from medical record,Fundus autofluorescence and full-field electroretinography change in chloroquine maculopathy after the drug cessations At first visit, 6month, 1year, 3year, 5year time point after drug cessation in eyes with chloroquine retinal toxicity Retrospective chart review from medical record | — |
Countries
Thailand
Contacts
Public ContactNida Wongchaisuwat
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed